The FDA has approved Miudella® (copper intrauterine system) for the prevention of pregnancy in females of reproductive potential for up to 3 years.

a part of Sebela Pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) granted approval of MIUDELLA ® (copper intrauterine system) for the prevention of pregnancy in ...

The Food and Drug Administration (FDA) has approved Miudella (copper intrauterine system [IUS]) for the prevention of ...

ROSWELL, Ga., Feb. 25, 2025 /PRNewswire/ -- Sebela Women's Health Inc., a part of Sebela Pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) granted approval of MIUDELLA ...

The company's first product, the Juveena Hydrogel System, is designed for preventing the formation or reformation of intrauterine adhesions following transcervical gynecological procedures.